TXMD logo

TherapeuticsMD, Inc. (TXMD)

Profile

Full Name

TherapeuticsMD, Inc.

Ticker

NASDAQ: TXMD

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

United States

IPO

May 9, 2007

Indexes

Not included

Website

https://www.therapeuticsmd.com

Employees

1

Key Details

Price

$1.10(+1.84%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.76M(+35.25% YoY)

Annual EPS

-$0.19(+80.61% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.10
    TXMD price is $1.10

    30-Day Relative Volume

    1.00
    TXMD 30-day relative volume is 1.00

    Price Performance

    Price Today change

    +1.84%
    TXMD price is up +1.84% today

    Price YTD change

    +27.9%
    TXMD price is up +27.9% since January 1st

    Price 1-year change

    -37.15%
    TXMD price is down -37.15% year-on-year

    Price 3-year change

    -88.53%
    TXMD price is down -88.53% over the past 3 years

    Price Range

    Price All-time high

    $8000.00
    TXMD price is currently -99.99% below its historical high of $8000.00

    Price 3-year low

    $0.70
    TXMD price is currently +57.13% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $12.73M
    TXMD market capitalization is $12.73 million

    Market cap 3-year change

    -85.92%
    TXMD market capitalization is down -85.92% over the past 3 years

    Market cap All-time high

    $1.96B
    TXMD market capitalization is currently -99.35% below its historical high of $1.96 billion

    Market cap sector rank

    18.26%
    TXMD market capitalization is higher than 18.26% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.36%
    TXMD shares outstanding is up +0.36% year-on-year

    Shares Outstanding 3-Year Change

    +22.81%
    TXMD shares outstanding is up +22.81% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.72
    TXMD beta is 0.72

    200-day SMA

    $1.10
    TXMD price is currently equal to its 200-day simple moving average

    50-day SMA

    $1.10
    TXMD price is currently equal to its 50-day simple moving average

    RSI

    44.67
    TXMD 14-day relative strength index is 44.67

    Volume

    1.00
    TXMD 30-day relative volume is 1.00

    ATR

    $0.04
    TXMD average true range is $0.04

    10-day Historical Volatility

    45.06%
    TXMD 10-day historical volatility is 45.06%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.76M
    TXMD annual revenue is $1.76 million

    Revenue Analysts estimate

    -
    TXMD annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    +35.25%
    TXMD annual revenue is up +35.25% year-on-year

    Revenue Sector rank

    38.83%
    TXMD annual revenue is higher than 38.83% of companies in Healthcare sector

    EPS

    EPS

    -$0.19
    TXMD annual earnings per share is -$0.19

    EPS Analysts estimate

    -
    TXMD annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +80.61%
    TXMD annual earnings per share is up +80.61% year-on-year

    EPS Sector rank

    71.18%
    TXMD annual earnings per share is higher than 71.18% of companies in Healthcare sector

    Profit

    Gross profit

    $1.25M
    TXMD annual gross profit is $1.25 million

    Gross margin

    71.10%
    TXMD annual gross profit margin is 71.10%

    Operating profit

    -$3.49M
    TXMD annual operating income is -$3.49 million

    Operating margin

    -198.30%
    TXMD annual operating profit margin is -198.30%

    Net income

    -$2.31M
    TXMD annual net profit is -$2.31 million

    Net margin

    -131.29%
    TXMD annual net profit margin is -131.29%

    Expenses

    Total expenses

    $5.25M
    TXMD annual total expenses is $5.25 million

    Operating expenses

    $5.25M
    TXMD annual total operating expenses is $5.25 million

    Cost of goods sold

    $509.00K
    TXMD annual cost of goods sold is $509.00 thousand

    Selling, general & administrative expenses

    $4.74M
    TXMD annual SGA is $4.74 million

    Depreciation and amortization

    $509.00K
    TXMD annual depreciation & amortization is $509.00 thousand

    Interest expense

    $0.00
    TXMD annual interest expense is $0.00

    Income tax

    -$31.00K
    TXMD annual income tax is -$31.00 thousand

    EBIT & EBITDA

    EBIT

    -$3.49M
    TXMD annual earnings before interest & taxes is -$3.49 million

    EBITDA

    -$2.98M
    TXMD annual EBITDA is -$2.98 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $38.82M
    TXMD annual total assets is $38.82 million

    Non current assets

    $28.90M
    TXMD annual long term assets is $28.90 million

    Current assets

    $9.93M
    TXMD annual total current assets is $9.93 million

    Cash and cash equivalents

    $5.06M
    TXMD annual cash & cash equivalents is $5.06 million

    Accounts receivable

    -
    TXMD annual accounts receivable value is unknown

    Inventory

    $0.00
    TXMD annual inventory is $0.00

    Liabilities

    Total liabilities

    $11.45M
    TXMD annual total liabilities is $11.45 million

    Long term liabilities

    $6.29M
    TXMD annual total long term liabilities is $6.29 million

    Current liabilities

    $5.17M
    TXMD annual total current liabilities is $5.17 million

    Accounts payable

    $258.00K
    TXMD annual accounts payable is $258.00 thousand

    Debt

    Total debt

    $7.17M
    TXMD annual total debt is $7.17 million

    Total debt 1-year change

    -10.37%
    TXMD annual total debt is down -10.37% year-on-year

    Long term debt

    $5.54M
    TXMD annual long term debt is $5.54 million

    Short term debt

    $1.63M
    TXMD annual short term debt is $1.63 million

    Equity & Capital

    Shareholders equity

    $27.37M
    TXMD annual stockholders equity is $27.37 million

    Book value

    $27.37M
    TXMD annual book value is $27.37 million

    Retained earnings

    -$951.82M
    TXMD annual retained earnings is -$951.82 million

    Working capital

    $4.76M
    TXMD annual working capital is $4.76 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $1.17M
    TXMD annual cash flow from operations is $1.17 million

    Cash from operations 1-year change

    +105.07%
    TXMD annual cash flow from operations is up +105.07% year-on-year

    Cash from investing

    $0.00
    TXMD annual cash flow from investing activities is $0.00

    Cash from investing 1-year change

    0%
    TXMD annual cash flow from investing activities has remained unchanged year-on-year

    Cash from financing

    $0.00
    TXMD annual cash flow from financing activities is $0.00

    Cash from financing 1-year change

    -100%
    TXMD annual cash flow from financing activities is down -100% year-on-year

    CAPEX

    CAPEX

    $0.00
    TXMD annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    TXMD annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    $1.17M
    TXMD annual free cash flow is $1.17 million

    Free cash flow 1-year change

    +105.07%
    TXMD annual free cash flow is up +105.07% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    71.10%
    TXMD annual gross profit margin is 71.10%

    Operating margin

    -198.30%
    TXMD annual operating profit margin is -198.30%

    Net margin

    -131.29%
    TXMD annual net profit margin is -131.29%

    ROA & ROE

    ROA

    -5.63%
    TXMD annual return on assets is -5.63%

    ROE

    -8.16%
    TXMD annual return on equity is -8.16%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    TXMD price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    TXMD price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.47
    TXMD price to book ratio is 0.47

    PB ratio Sector rank

    24.25%
    TXMD price to book ratio is higher than 24.25% of companies in Healthcare sector

    PS Ratio

    PS ratio

    4.97
    TXMD price to sales ratio is 4.97

    PS ratio Sector rank

    58.94%
    TXMD price to sales ratio is higher than 58.94% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $13.27M
    TXMD enterprise value is $13.27 million

    Enterprise value Sector rank

    25.21%
    TXMD enterprise value is higher than 25.21% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -5.86
    TXMD EV/EBITDA is -5.86

    EV/EBITDA Sector rank

    20.57%
    TXMD EV/EBITDA is higher than 20.57% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.92
    TXMD annual current ratio is 1.92

    Quick ratio

    1.92
    TXMD annual quick ratio is 1.92

    Leverage

    Debt to equity

    0.26
    TXMD annual debt to equity ratio is 0.26

    Interest coverage ratio

    -
    TXMD annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    6
    TXMD piotroski f-score is 6

    Altman Z-Score

    -33.76
    TXMD altman z-score is -33.76

    Analyst ratings

    Recent major analysts updates

    Aug 17, 23 Cantor Fitzgerald
    Neutral
    Jul 13, 22 Cantor Fitzgerald
    Neutral
    Jun 7, 22 HC Wainwright & Co.
    Neutral
    May 6, 22 Cantor Fitzgerald
    Neutral
    Mar 11, 22 HC Wainwright & Co.
    Buy
    Nov 12, 21 HC Wainwright & Co.
    Buy
    Aug 7, 20 Jefferies
    Underperform
    May 19, 20 JP Morgan
    Neutral
    May 7, 20 H.C. Wainwright
    Buy
    Apr 16, 20 Stifel
    Buy

    Institutional Ownership

    Screeners with TXMD included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Best performing stocks YTD
    • What is the ticker symbol for TherapeuticsMD, Inc.?
    • Does TherapeuticsMD, Inc. pay dividends?
    • What sector is TherapeuticsMD, Inc. in?
    • What industry is TherapeuticsMD, Inc. in?
    • What country is TherapeuticsMD, Inc. based in?
    • When did TherapeuticsMD, Inc. go public?
    • Is TherapeuticsMD, Inc. in the S&P 500?
    • Is TherapeuticsMD, Inc. in the NASDAQ 100?
    • Is TherapeuticsMD, Inc. in the Dow Jones?
    • When was TherapeuticsMD, Inc.'s last earnings report?
    • When does TherapeuticsMD, Inc. report earnings?

    What is the ticker symbol for TherapeuticsMD, Inc.?

    The ticker symbol for TherapeuticsMD, Inc. is NASDAQ:TXMD

    Does TherapeuticsMD, Inc. pay dividends?

    No, TherapeuticsMD, Inc. does not pay dividends

    What sector is TherapeuticsMD, Inc. in?

    TherapeuticsMD, Inc. is in the Healthcare sector

    What industry is TherapeuticsMD, Inc. in?

    TherapeuticsMD, Inc. is in the Specialty & Generic Drug Manufacturers industry

    What country is TherapeuticsMD, Inc. based in?

    TherapeuticsMD, Inc. is headquartered in United States

    When did TherapeuticsMD, Inc. go public?

    TherapeuticsMD, Inc.'s initial public offering (IPO) was on May 9, 2007

    Is TherapeuticsMD, Inc. in the S&P 500?

    No, TherapeuticsMD, Inc. is not included in the S&P 500 index

    Is TherapeuticsMD, Inc. in the NASDAQ 100?

    No, TherapeuticsMD, Inc. is not included in the NASDAQ 100 index

    Is TherapeuticsMD, Inc. in the Dow Jones?

    No, TherapeuticsMD, Inc. is not included in the Dow Jones index

    When was TherapeuticsMD, Inc.'s last earnings report?

    TherapeuticsMD, Inc.'s most recent earnings report was on May 13, 2024

    When does TherapeuticsMD, Inc. report earnings?

    The date for TherapeuticsMD, Inc.'s next earnings report has not been announced yet
    On this page